Drug Facts

Sixty percent of the available label space

On this page11

What the clause does What you get Read what that implies So the clause is a relief valve, not a solution Which makes label area a specification And it is measurable Available label space is the phrase to understand Our shelf, against that The small end is where the trouble is Decide this before the brand design References

A regulation that triggers on a percentage of your label area. That is a rule about the bottle.

What the clause does

Where the Drug Facts labeling would occupy more than 60 percent of the available label space, a set of format relaxations becomes available.

What you get

A continuation title at no smaller than 7-point, headings at the larger of 7-point or one point greater than the text, reduced leading provided ascenders and descenders do not touch, bullets that need not be vertically aligned, and the box omitted where color contrast distinguishes the labeling.

Read what that implies

The relaxations are small and specific. This is not permission to shrink the panel; it is permission to tighten the typography by a point and drop a box.

So the clause is a relief valve, not a solution

If your panel needs 90 percent of the label, these concessions will not rescue it. The answer at that point is a bigger container, a carton or an extended-content label.

Which makes label area a specification

Not a nice-to-have. For a monograph product, the printable area of the container is as much a requirement as its capacity, and it is the one nobody puts on the brief.

And it is measurable

Height of the straight wall, usable circumference, and whatever the front panel has to carry. Two numbers and a layout answer the question before anything is ordered.

Available label space is the phrase to understand

It is the area actually available for labeling on the container, which is not its surface area. A shoulder, a taper and a base are surface and not label space.

Our shelf, against that

628 containers with a median of 237 mL, 370 of them over 6 oz and 187 over 16 oz. The large end is where a Drug Facts panel sits comfortably at 6-point.

The small end is where the trouble is

A 2 oz jar of scalp treatment with a monograph claim is the hardest packaging problem in this property, and the honest answer is often a carton or a booklet label rather than a cleverer layout.

Decide this before the brand design

A designer handed a bottle and a Drug Facts panel at the same time will make it work. One handed the bottle first and the panel later will ask for a smaller type size, and that is not available.

References

21 CFR 201.66(d), the Drug Facts format. The title "Drug Facts" "shall appear in a type size larger than the largest type size used in the Drug Facts labeling". Headings are set at "the larger of either 8-point or greater type, or 2-point sizes greater than the point size of the text", and all other content is "no smaller than 6-point type". Paragraph (d)(10) relaxes the format where the Drug Facts labeling would occupy more than 60 percent of the available label space: a continuation title at no smaller than 7-point, headings at the larger of 7-point or one point over the text, reduced leading provided ascenders and descenders do not touch, bullets that need not be vertically aligned, and the enclosing box omitted where color contrast distinguishes the labeling. law.cornell.edu

The Davis Pack Supply catalog, measured 18 October 2026. The hair care shelf is 1,261 rows: 628 containers and 633 closures. 5 mL to 2,000 mL with a median of 237; 370 containers over 6 oz, 330 over 8 oz, 187 over 16 oz and 54 over 32 oz. 342 PET, 110 glass, 94 HDPE, 73 PP, 9 steel. 349 bottles, 260 jars, 9 tins, 5 tubs and pails, 3 jugs and 2 tubes. Closures: 384 continuous thread, 43 dropper assemblies, 39 lotion pumps, 27 dome lids, 26 disc top, 16 flip top, 14 phenolic, 12 lug and twist, 11 treatment pumps, 9 round tubs, 7 buttress. Necks: 86 at 89-400, 70 at 38-400, 59 at 24-410, 58 at 70-400, 51 at 28-410, 42 at 45-400.

Written from 21 CFR part 358 subpart H, 21 CFR 201.66 and the catalog as it stood on 18 October 2026. Whether a particular product is a cosmetic or a drug turns on its intended use, which is established by what you say about it; no page here can make that determination for you. Cosmetic labeling, facility registration and product listing are covered in the grooming property and not repeated.